Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Betsy S. Atkins, a director of Enovix Corporation (ENVX), reported sales of warrants that had been distributed to her on July 21, 2025. The Form 4 shows sales on August 15 and August 18, 2025 of publicly traded warrants exercisable to purchase common stock at $8.75 per share and expiring October 1, 2026. The reporting shows a weighted-average sale price for the related underlying shares between $1.48 and $1.53, and indicates the warrants were sold in the public market at prevailing prices. After the transactions, the reporting person no longer beneficially owned any of the Warrants previously distributed on July 21, 2025.
Kristina Truong, Chief Accounting Officer of Enovix Corp (ENVX), received a fully vested award of restricted stock units (RSUs) as a quarterly bonus on 08/15/2025. The filing shows 4,138 shares of common stock issued upon vesting of those RSUs and the withholding of 2,187 shares to satisfy tax obligations at a reported share withholding price of $10.21. Following these transactions, the reporting person’s beneficial ownership is reported as 207,798 shares. The filing states that 171,225 of the reported holdings are shares issuable upon settlement of RSUs granted to the reporting person.
Enovix Corporation (ENVXW) submitted a Form 144 to notify a proposed sale of warrants. The filing identifies 30,187 warrants to be sold through Piper Sandler & Co., with an aggregate market value of $53,430.99 and an approximate sale date of 08/15/2025. The warrants were acquired as a dividend on 07/21/2025 from the issuer, and the acquisition payment date is recorded as 07/21/2025. The filing reports 196,600,013 shares or units outstanding for the class and discloses no securities sold by the same person in the past three months. The filer certifies no undisclosed material adverse information.
Enovix insider transaction: The Form 4 reports that 500,000 publicly-traded warrants were transferred as a bona fide gift from the Rodgers Massey Revocable Living Trust, for which Thurman J. Rodgers is trustee and retains voting and dispositive power, to a donor advised fund. The Warrants were originally distributed by the issuer on July 21, 2025 at no cost and each Warrant is exercisable for one share of common stock at an $8.75 exercise price. Following the reported gift, the Reporting Person beneficially owns 1,914,466 warrants indirectly through the Trust. The Warrants expire on October 1, 2026, subject to early-acceleration conditions in the Warrant Agreement.
Kristina Truong, identified as the issuer's Chief Accounting Officer, reported a transaction in Enovix Corp (ENVX) common stock on 08/13/2025. The filing shows 1,013 shares were disposed at a price of $10.98 via transaction code F, which the filer explains reflects withholding of shares to satisfy tax-withholding obligations on vested restricted stock units (RSUs). After the transaction, the reporting person beneficially owned 205,847 shares (direct), which includes 171,225 shares issuable upon settlement of outstanding RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/14/2025.
Ajay Marathe, Chief Operating Officer of Enovix Corporation, reported a routine equity withholding transaction on 08/14/2025. The filing shows 7,338 shares of common stock were disposed of at a price of $10.50 to satisfy tax withholding in connection with the vesting of restricted stock units (RSUs). After the withholding, the reporting person beneficially owns 1,157,015 shares, which includes 810,783 shares issuable upon settlement of RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Thurman J. Rodgers, a trustee of the Rodgers Massey Revocable Living Trust and a 10% owner and director of Enovix Corporation (ENVX), reported a bona fide gift of 500,000 publicly-traded warrants to a donor advised fund. The Warrants were originally distributed by the issuer on July 21, 2025 at no cost and each entitles the holder to purchase one share of common stock at an $8.75 exercise price. The reported transaction date is 08/14/2025. After the gift, the Reporting Person retains beneficial interest in Warrants underlying 2,414,466 shares held in the Trust. The Warrants expire on October 1, 2026, subject to early-acceleration terms in the Warrant Agreement.
Enovix Corporation appointed John Daniel (Dan) McCranie to its Board of Directors effective August 12, 2025, increasing the Board to eight members and identifying him as an independent director. Mr. McCranie previously served on Enovix’s Board and had been an audit committee member and chair of the compensation committee before his resignation effective January 20, 2023.
Under the company’s Non-Employee Director Compensation Policy, Mr. McCranie will receive a prorated annual cash retainer of $50,000, an initial restricted stock unit grant valued at $275,000 (vesting quarterly over three years), and a prorated annual RSU grant valued at $195,000 (vesting quarterly over one year or until the next annual meeting). He will sign the company’s standard director indemnification agreement. A press release is filed as Exhibit 99.1.
Arthi Chakravarthy, the Chief Legal Officer of Enovix Corporation, reported a transaction dated 08/08/2025 reflecting the withholding of 934 shares to satisfy tax-withholding obligations upon the vesting of restricted stock units (RSUs). The shares were withheld at an effective price of $10.78. After this withholding, the reporting person beneficially owns 428,183 shares directly, which includes 337,993 shares issuable upon settlement of RSUs that remain part of her beneficial stake. The filing shows no derivative transactions reported and is signed on 08/12/2025.
Raj Talluri, President and CEO and director of Enovix Corporation, reported a routine equity withholding related to RSU vesting on 08/08/2025. The filing shows 4,292 shares of the issuer's common stock were withheld to satisfy tax withholding obligations at a reported price of $10.78 per share in connection with the vesting of restricted stock units.
After the withholding, the reporting person is recorded as beneficially owning 2,400,818 shares (direct). That total explicitly includes 1,887,185 shares issuable upon settlement of outstanding RSUs granted to the reporting person.